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Methods of Shortening the Anestrous Period in Mares
J. A. Smith, DVM*
W. R. Redding, DVM**
Introduction
The fact that the horse is seasonally poly-
estrous makes this species a reproductive chal-
lenge for horsemen and equine practitioners.
Mares will show several estrous cycles during
the breeding season assuming pregnancy does
not terminate estrus. The receptive season is
limited to such a length oftime that parturition
occurs in the spring of the year. The challenge
arises when trying to devise methods that would
allovl parturition to take place earlier in the
year. This is desirable only because most breed
registries have imposed an arbitrary birthdate
of January 1st to all foals born in a single year.
Each yearling is considered one year of age on
January 1 of each year regardless of their ac-
tual age. Concern among horseowners regard-
ing this stipulation lies in the eligibility oftheir
horses for age limited races, shows, or events.
In order to be competitive, actual birthdates as
close to January 1 are desired.
The gestation length of the mare is approxi-
mately 330-340 days. Therefore, breeding dates
in February, March, and early April with the
resulting January, February, and March foal-
ings, offer the greatest competitive edge.
However, in the Northern Hemisphere, 75 to
80% of the mares are in deep winter anestrous
or early transition at this time.6
In a seven year study, it was found that the
mean date of first ovulation for Thoroughbred
and Quarterhorse mares was Aprillst.14 June
and July are the months where peak sexual be-
havior can naturally be observed, while Novem-
ber usually marks the beginning of winter
anestrous.
*Dr. Smith is a 1989 graduate of the College of
Veterinary Medicine.
**Dr. Redding is a resident and adjunct in-
structor in the Department ofClinical Sciences
in the College of Veterinary Medicine at Iowa
State University.
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Neural and Endocrine Control of the Estrous
Cycle
The main contributing factor in the seasonal
breeding pattern of the horse appears to be
directly correlated to photoperiod. During the
spring and summer months, with increasing
daylight periods peaking at 15 to 16 hours,
ovarian activity is stimulated while the shorter
daylight (9 to 10 hours) during winter months
inhibits ovarian activity.6 Researchers have
found that exposure of the retina to light sends
a neural stimulus through the optic nerve to the
pineal gland in the brain.5 It is then thought
that the pineal gland functions as a neuroendo-
crine transducer converting neural input to
hormonal output. The major hormone pro-
duced by the pineal gland affecting reproduc-
tion seems to be melatonin. It has been shown
that a depletion in gonadotropin releasing
hormone (GnRH) resulted in ovariectomized
mares after the insertion of melatonin im-
plants.15 The synthesis ofmelatoriin is inversely
related to the duration ofretinal light exposure.
Increasing light causes a decrease in melatonin
production while decreasing light results in
increased production.6 Therefore, the activity
of the ovaries and the seasonal breeding pat-
tern of horses can be directly related to the
duration of light exposure, melatonin synthe-
sis, and ultimately GnRH production.
GnRH is a decapeptide produced by the
hypothalamus.l Through a system of portal
vessels, GnRH is transported from the hypo-
thalamus to the adenohypophysis (anterior
pituitary) where it assists in controlling the
release of follicle-stimulating hormone (FSH)
and luteinizing hormone (LH).5 It is thought
that the frequency ofpulsatile release ofGnRH
determines the rate of release of either FSH or
LH. High frequency pulses cause release ofLH
while low rates result in FSH release.1o
Follicular development, ovulation, and cor-
pus luteum (CL) formation by the ovaries are
all cOIltrolled by FSH and LH. It is recognized
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that a bimodal release of FSH occurs with two
peaks per estrous cycle at 10 to 11 day intervals.
Two waves of follicular growth coincide with
the two FSH peaks.6Those follicles that result
from the FSH stimulation at days 9 to 12 reach
maturation by the end of estrus.5 LH is the go-
nadotropin responsible for ovulation. LH levels
begin to rise at the beginning of estrus.6 A
selection mechanism, theorized to be follicular
LH receptor sites, designates one, sometimes
two, and rarely three or more follicles to un-
dergo final maturation and ovulation. Peak LH
occurs approximately two days post ovulation
and returns to baseline concentrations by days
five or six and remains low until the next es-
trus.5
The prolonged rise in LH, from the begin-
ning of estrus to two days post ovulation, is
necessary for the stimulation offollicular gran-
ulosa cells to transform into luteal cells. The
luteal structure that first develops is termed
the corpus hemorrhagicum which matures to
become a CL. This structure begins to produce
progesterone by day one or two after ovulation.
The progesterone production by the CL contin-
ues to rise until around day 6, when concentra-
tions then plateau. The mature CL will produce
progesterone at levels equalling 8 to 10 ng/ml
until approximately day 14 or 15 of the estrous
cycle. Luteolysis of the CL occurs at this time,
in response to prostaglandin F2 (PGF2a) being
released from the endometrium of the uterus.
Progesterone concentrations rapidly fall to levels
less than 1 ng/ml within one to two days, and
the mare returns to estrus.5 Progesterone func-
tions in coordinating the estrous cycle through
negative feedback effects on LH secretion and
acts as the "hormone of pregnancy". It blocks
estrus behavior, suppresses myometrial activ-
ity, promotes endometrial secretion, and acts
synergistically with estrogens to promote uter-
ine and mammary growth.11 Therapeutic usage
of progesterone will be presented under the
section discussing the transitional phase.
Artificial Light
It is most likely that the onset of winter
anestrous occurs due to insufficient levels of
LH. It has been shown that mares usually enter
winter anestrous due to failure of ovulation
following normal regression ofa CL. This is the
result of the shortening daylight period which
stimulates melatonin production resulting in
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decreased GnRH release.
Better understanding of the reproductive
pattern ofmares and its relationship to photop-
eriods has led to the development of exogenous
means to control it. It has become a popular
practice of breeding farms to start artificial
light supplementationinlate November or early
December to achieve a breeding season starting
in February. The method most often used is to
extend light exposure past sunset by artificial
means to equal 16 total hours per day.6 The
light intensityrequirement is 10-12 foot candles.
This can be provided by one 200-watt incandes-
cent light bulb per 12 by 12 foot box stall. 15
A simple method of testing the intensity of
light in a stable is by use ofa 35mm camera with
a through-the lens light meter. With the film
speed setting at ASA 400 and the shutter speed
setting at 0.25 seconds, a clean, plain white
styrofoam cup is placed over the lens. The cup
acts as a diffuser and averages the light from all
the point sources in the stable. The aperture
setting is read with the camera held at about
the height ofa horses' eye. Readings ofgreater
than f4 indicates an adequate light intensity.15
An alternative to stall lighting is to use
lighted paddocks. Several mares can be placed
in properly lighted paddocks at the end of the
day. The lights can be controlled by timers and
automatically turned off after the required 16
hours of total light has been met. Automatic
gate openers can then be set to allow the mares
to return to pasture.15
Transitional Phase
The use of progesterone or synthetic pro-
gestogens have been used to try and shorten the
anestrous period.12 However, this treatment is
only efficacious when used on mares that have
already advanced into the transitional phase of
the estrous cycle. This period occurs between
deep winter anestrous and the onset of normal
estrous cycles. During this time, estrous behav-
ior is irregular and inconsistent. The ovaries
are larger than during winter anestrous and
begin developing many 10-20 mm follicles. The
nuITLber of follicles remain high until one is
selected to become the preovulatory follicle.
Prolonged estrus behavior can last from one
week to four months or more.6
Some of the original work in the area of
progesterone treatments for mares in transi-
tion, showed that 100 mg ofprogesterone in oil,
93
administered once daily for seven days, termi-
nated the prolonged estrus in approximately
two days and decreased the abundant follicular
activity. Following the last injection the mares
returned to estrus within three days and nor-
mal cyclicity continued.5 Since then an oral
progestogen (altrenogest, Regu-mateR, Hoechst
Roussel) has been developed that has shown
efficacy in the treatment oftransitional nlares.
The recommended dosage for this product is 1
ml per 110 pounds ofbody weight (0.044 mg/kg),
given once daily for 15 consecutive days. Re-
turn to estrus has been shown to occur within
three days post treatment and normal cyclic
activity follows. 11
A third method consists of a combination of
progesterone and estradiol-17B. Ten daily
intramuscular injections of 150 mg of proges-
terone plus 10 mg of estradiol-17B has shown
good success. While estrogen alone stimulates
LH release, when combined with progesterone
it causes suppression of LH to near nonde-
tectable levels.
It is important to the success of these treat-
ments that, prior to their initiation, the mare
must have very active ovaries containing sev-
eral follicles that are at least 15 to 25 mm in
diameter. The mechanism of action making
progesterone or progesterone plus estradio1-
17B, effective for treatment oftransitional mares
is blockage of LH release. What is most likely
occurring in these mares is insufficient produc-
tion ofLH. These LH levels are not capable of
causing final follicular maturation and ovula-
tion to take place. While being suppressed in
the presence of progesterone,LH levels surge
after treatment is stopped. The mare returns to
estrus, and normal follicular maturation, ovu-
lation and CL formation results.
Research is currently underway to develop a
better method of progesterone administration.
Intramuscular injections, as well as, oral dos-
ing is labor intensive, and requires adequate
facilities. Therefore, creation of prolonged re-
lease devises, such as, impregnated vaginal
sponges or subcutaneously injectable implants
would be very beneficial.
Induction of Ovulation During Anestrus
Pituitary Extract
The first report of successful induction of
ovulation in mares during winter anestrous by
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means ofexogenous hormones was accomplished
by Wisconsin workers. In this same study they
were also the first to achieve induction ofmul-
tiple ovulation in mares. Their experiment was
conducted to test the hypothesis that ovulation
could be induced in winter anestrous mllres
with equine pituitary extracts. Mares chosen
for the study were only those with small, inac-
tive ovaries containing follicles less than 10 mm
in diameter. Also, venous blood was collected
one week prior to the start ofthe experiment for
progesterone quantitations. Only mares with a
peripheral plasma progesterone concentration
ofless than 1 ng/ml were included in the experi-
ment. This criteria proved that the mares were
truly anestrus with no ovarian activity present.
The experiment resulted in 87% ofall treated
mares ovulating following 14 days oftwice daily
injections. Of these mares, 58% had two or
more ovulations per estrus. The days to first
ovulation averaged 14 to 15 days from the start
of treatment. No ovulations occurred in con-
trolled mares during the time the experiment
was conducted.3
GnRH and Progesterone
Since the experiment conducted by the
Wisconsin workers, attempts to induce ovula-
tion and multipleovulations in winter anestrous
mares has involved treatments with GnRH.
Some of the original work was conducted by
Evans and Irvine. It was their intention to
stimulate, by exogenous administration of
GnRH and progesterone, the events that take
place in the normal ovulatory cycle. Courses of
GnRH were administered at approximately ten
day intervals. Progesterone was administered
from days six to 23 in attempt to reproduce the
luteal phase. In the experiment, 13 deeply
acyclic mares treated with this regimen devel-
oped follicles ranging in size from 20-70mm,
that subsequently ovulated. Only one of five
untreated.mares showed any ovarian develop-
ment during this same time period.4
Pulsatile GnRH Administration
Since the work conducted by Evans and Irv-
ine, A. L. Johnson et al. has conducted a study
evaluating the effectiveness of pulsatile GnRH
administration to induce multiple ovulations in
anestrous mares. The experiment was con-
ducted in mid January to the first week in Feb-
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ruary. Mares were randomly allotted to one of
four treatment groups. A control group was
used along with one group receiving 2 ug GnRhi
hour, another receiving 20 ug GnRHihour and
the fourth 100 ug GnRHihour. Administration
was via an indwelling infusioncatheter. The
GnRH was given as a single five-second pulse in
118 ul saline. The results of the experiment
showed failure ofall control mares to ovulate or
show any significant follicular development.
The number of days to first ovulation was
comparable in all three treated groups; how-
ever, the number of follicles ovulating was sig-
nificantly higher in groups receiving 20 ug
GnRHihour and 100 ug GnRHihour. Double
ovulations occurred in three of nine mares in
the 2 ug GnRHlhour group. The normal inci-
dence of double ovulations in the equine is
estimated to range from four to 43%. In consid-
eration of this fact th.ese researchers suggest
that the 2 ug GnRHlhour group most closely re-
semble a normal ovulatory response.9
GnRH Implants
Most recently, Australian researchers (J. H.
Hyland et al.) have developed a means to
administer a constant infusion of GnRH. Con-
tinuous 28 day release of GnRH is achieved by
surgically implanting an osmotic minipump
under the skin of the neck.8 Various pump
dosages ranging from 100 ng/kg/28 days to 400
ng/kg/28 days are used depending on the size of
the mare. Ovulation occurs on the average in 20
days (range:5-32 days) following pump inser-
tion. Normal cyclic activity is then observed
post ovulation with the pump in place and after
it's removal. These individuals are now in the
process of conducting field trails in the United
States, using privately owned mares.
While the osmotic minipump being used
by the Australian group has shown that
constant infusion of GnRH via an implant will
induce ovulation in acyclic mares, it is still a
less than adequate device for commercial
usage. R. H. Douglas ofBET Laboratories is in
the process of developing a more practical
implant. By the process ofmicroencapsulation,
he feels an implant can be made that would
allow it to be injected subcutaneously and
remain impalpable through the skin. This type
of implant dissolves slowly releasing daily lev-
els of GnRH sufficient to induce ovulation.
Eventually the implant is completely dissolved
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eliminating the need for removal. In an experi-
ment conducted by W. R. Allen, testing the
effectiveness of a GnRH analogue for inducin-
govulation in acyclic mares, a similar implant
as described above was used. It was injected
under the skin via a 14 gauge needle and was
not palpable after its insertion. Results compa-
rable to those recorded by Hyland were achieved
in this study.1
Gonadotropins
Direct stimulation of ovarian activity in
anestrous mares by exogenous gonadotropins
(rather than indirectly, by use of GnRH), may
be the eventual treatment for this condition.
The genetic code of equine FSH and LH has
been mapped. Large quantities could be pro-
duced by recombinant DNA techniques if pro-
duction of these hormones were warranted by
industrial demand. Research protocols involv-
inggonadotropin regimens will most likely soon
result. It may be found that mimicking the
normal estrous cycle exogenously through
gonadotropin supplementation can stimulate
ovulation in acyclic mares as well. Then more
exact daily hormone levels could be determined
in order to achieve minimal requirements.
Perhaps an FSH inlplant followed by an injec-
tion of LH on a determined day will be the
treatment of the future.
Added benefits of having equine gona-
dotropins would occur in the area of superovu-
lation research. In the past equine pituitary
extract has been most effective in stimulating
multiple ovulations. Equine pituitary extract,
however, is quite expensive to produce, limiting
its use in this area.
Also equine LH would be superior over the
currently used Human chorionic gonadotropin
(hCG). hCGis widely used in the equine breed-
ing industry to induce ovulation in cyclic mares.
hCG can be given at dosages of 2000-3000 IV
intravenously during early estrus when there
is one large dominant follicle. It has been
shown, in order to be effective, the follicle should
be equal to, or greater than, 35 mm in diameter. 7
Mares responding to h CGusually ovulate within
48 hours fd1lowing the injection. With the
ability to control ovulation, avoidance of stallion
overuse as well as, minimizing uterine con-
tamination by penile microorganism, particu-
lary in subfertilemares, can be achieved. Mares
may produce antibodies to the globulin compo-
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nent ofhCG limiting its use for multiple treat-
ments. Subsequently equine LH would be
superior.
Conclusion
At the present time the method that is most
feasible and practical for shortening the
anestrous period is an artificial lighting pro-
gram. Added to this, development of a good
teasing program starting in early February is
crucial. Examination of all mares not showing
normal cyclicity should then be done. Rectal
palpation and ultrasound of the ovaries and
reproductive tract are important diagnostic aids,
as are vaginoscopic exams and plasma proges-
terone levels. Those mares presenting with
prolonged, abnormal estrus with active ovaries,
relaxed, pale, dry cervix and plasma progester-
one less than 1.0 ng/ml should be considered to
be in the transition phase. Those failing to
show estrus and having active ovaries, tight,
pale, dry cervix and plasma progesterone
greater than 1.0 ng/ml should be considered to
contain a persistent CL and can be successfully
treated with prostaglandins. ll
Alternatives to the above approach such as
the use of exogenous GnRH or gonadotropins
offers exciting possibilities. However, as we
wait for further development in these tech-
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